Pillstats
Rx only · Capsule · Oral

Clomipramine Hydrochloride

Brands: Anafranil · Clomipramine Hydrochloride

15 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US47 NDCs
15 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06AA04
RxCUI (US)2597
US makers15 labelers
Packages119
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 49 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.082$0.163$0.245$0.326Dec 2025Apr 2026Jul 2026
$0.230
Latest avg · Jul 22, 2026
-19%
Since Dec 17, 2025
15
Active US suppliers
30%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

9.2K18K28K37K2025 Q12025 Q22025 Q32025 Q42026 Q1
29K
Rx · 2026 Q1
1.7M
Units dispensed
-4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it15 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown18SUPPLYING
Proficient Rx LPunknown18SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown12SUPPLYING
Micro Labs Limitedunknown10SUPPLYING
Rising Pharma Holdings, Inc.unknown9SUPPLYING
NorthStar Rx LLCunknown9SUPPLYING
Leading Pharma, LLCunknown8SUPPLYING
Aurobindo Pharma Limitedunknown8SUPPLYING
Lifestar Pharma LLCunknown6SUPPLYING
SpecGx LLCunknown6SUPPLYING
Ajanta Pharma USA Inc.unknown6SUPPLYING
Golden State Medical Supply, Inc.unknown3SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
American Health Packagingunknown2SUPPLYING
Major Pharmaceuticalsunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 22, 2025
    RECALLRecall (Class II): clomiPRAMINE Hydrochloride, Capsules, USP, 75 mg, packaged in a) 30-count bottles (NDC 16714-851-01), b) 90-count bottl…

    cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the US

  • Oct 22, 2025
    RECALLRecall (Class II): clomiPRAMINE Hydrochloride, Capsules, USP, 50 mg, packaged in a) 30-count bottles (NDC 16714-850-01), b) 90-count bottl…

    cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the US

  • Oct 22, 2025
    RECALLRecall (Class II): clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottl…

    cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the US

  • Aug 23, 2022
    RECALLRecall (Class III): ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pha…

    Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules — Recalling firm: Leading Pharma, LLC — Nationwide within the United States